April 4, 2022 10:54 AM EDT
Coronavirus

Covid-19 roundup: FDA grants pri­or­i­ty re­view to Roche's Actem­ra; WHO sus­pends UN sup­ply of Co­v­ax­in — re­port

Paul Schloesser

Associate Editor

Af­ter more than 9 months af­ter the WHO gave the all-clear on IL-6 drugs for use in pa­tients with Covid-19, in­clud­ing Roche’s im­muno­sup­pres­sant and rheuma­toid …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

Deer­field wins fight to ac­quire Sin­gu­lar Ge­nomics, beat­ing out Tang Cap­i­tal’s Con­cen­tra

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

A service from the Financial Times